Neumora

Neumora company information, Employees & Contact Information

Explore related pages

Related company profiles:

Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism of action where we can leverage our precision neuroscience approach. Our pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora is committed to addressing some of the most prevalent brain health disorders and transforming the standard of care for millions of patients living with brain diseases. Learn more about Neumora and career opportunities on our website below.

Company Details

Employees
122
Founded
-
Address
65 Grove Street, Suite 102, Watertown,ma 02472,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Watertown, MA
Looking for a particular Neumora employee's phone or email?

Neumora Questions

News

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 - Yahoo Finance

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 Yahoo Finance

Neumora Therapeutics to Host Virtual R&D Day Highlighting Innovative Therapeutics Pipeline on October 27, 2025 - Quiver Quantitative

Neumora Therapeutics to Host Virtual R&D Day Highlighting Innovative Therapeutics Pipeline on October 27, 2025 Quiver Quantitative

Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer - Business Wire

Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer Business Wire

Neumora Therapeutics Appoints Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development - citybiz

Neumora Therapeutics Appoints Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development citybiz

Neumora Therapeutics Announces $112 Million Series B Financing - Business Wire

Neumora Therapeutics Announces $112 Million Series B Financing Business Wire

Top Neumora Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant